How Much CBD and THC Enters the Bloodstream?

The rise in cannabis use has led to a number of online shops offering cannabinoid products, including cannabidiol (CBD), that have not undergone diligent pre-clinical and clinical testing. In response, scientists have developed an assay to measure the concentration of cannabinoids in human blood plasma during the use of cannabinoid-containing products.

The most abundant phytocannabinoids are Δ9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) and these are metabolized into monohydroxylated and carboxy metabolites by cytochrome P450 isozymes, such as CYP2C9, CYP2C19, and CYP1A1. The assay developed by the authors provides a way to measure the CBD and THC in the blood plasma.

Blood sample being sent off for analysis.umarazak | Shutterstock

Preparing the samples

The donated plasma was frozen and shipped to the lab and then to extract the plasma, it was first mixed with either calibration standard or methanol, and working internal standard solution was added. The sample was then shaken and centrifuged to obtain the supernatant. This supernatant was dried under nitrogen to obtain dried samples. These samples were further reconstituted with acetonitrile and water.

How much CBD and THC enters the bloodstream?

These samples were then analyzed using a UHPLC system under isocratic conditions. The analytes were detected using electrospray ionization mode in the mass spectrometer. While developing the method, the authors also optimized chromatography, mass spectrometer conditions.

Three different samples were analyzed and compared to internal standards. In addition to CBD and THC, other cannabinoids with similar and different transitions of mass were included to ensure that their presence did not interfere with the assay, and for qualitative monitoring.

Retention times were used to identify the analytes. The retention time for CBD and THC were 2.27 and 4.45 min, while the internal standard, including D3-CBD and D3-THC, eluted at 2.25 and 4.42 min.

THC and CBD also had distinct chromatography peaks that did not interfere with other cannabinoid compounds. As CBD and THC have the same mass, they were present in the same mass spectrometer selected channel.

The plasma concentration of CBD was 7 ng/ml and 5.2ng/ml for THC. These numbers are similar to what has been previously reported, reinforcing the results of the study.

Validation and accuracy of the assay

The assay was calibrated and calibration curves were created using the peak area ratios versus analyte concentration. The intra-and inter-day accuracy and precision were less than 5.6%. The accuracy of the assay was from -4.6% to 9.2% and the precision was from 1.14% to 13.1%.

Stability of the sample

The sample was analyzed for the stability of CBD and THC at different conditions. The difference in the stability of samples and freshly prepared samples ranged from -12.6% to 9.8%, suggesting that the samples were degrading within acceptable limits. CBD and THC were stable in plasma for a month when kept in -70°C, could survive three cycles of freeze and thaw, and sit on the bench for 24 hours when kept at 20 °C.

This study shows the relevance of a UHPLC-MS/MS method to determine the levels of CBD and THC from human blood plasma. This can also be used to monitor other cannabinoid compounds, such as THVC, CBN, CBDA, and metabolites of THC, such as 11OH-THC and THC-COOH. The assay could detect as low as 0.5ng/mL concentrations of CBD and THC, thus providing a method to determine variabilities and levels of cannabinoids in various products.

Source

Ocque et al. (2019) Development and validation of an assay to measure cannabidiol and Δ9-tetrahydrocannabinol in human EDTA plasma by UHPLC-MS/MS. Journal of Chromatography B (https://doi.org/10.1016/j.jchromb.2019.03.002)

Further Reading

Last Updated: Jul 25, 2019

Dr. Surat P

Written by

Dr. Surat P

Dr. Surat graduated with a Ph.D. in Cell Biology and Mechanobiology from the Tata Institute of Fundamental Research (Mumbai, India) in 2016. Prior to her Ph.D., Surat studied for a Bachelor of Science (B.Sc.) degree in Zoology, during which she was the recipient of an Indian Academy of Sciences Summer Fellowship to study the proteins involved in AIDs. She produces feature articles on a wide range of topics, such as medical ethics, data manipulation, pseudoscience and superstition, education, and human evolution. She is passionate about science communication and writes articles covering all areas of the life sciences.  

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    P, Surat. (2019, July 25). How Much CBD and THC Enters the Bloodstream?. News-Medical. Retrieved on December 05, 2019 from https://www.news-medical.net/life-sciences/How-Much-CBD-and-THC-Enters-the-Bloodstream.aspx.

  • MLA

    P, Surat. "How Much CBD and THC Enters the Bloodstream?". News-Medical. 05 December 2019. <https://www.news-medical.net/life-sciences/How-Much-CBD-and-THC-Enters-the-Bloodstream.aspx>.

  • Chicago

    P, Surat. "How Much CBD and THC Enters the Bloodstream?". News-Medical. https://www.news-medical.net/life-sciences/How-Much-CBD-and-THC-Enters-the-Bloodstream.aspx. (accessed December 05, 2019).

  • Harvard

    P, Surat. 2019. How Much CBD and THC Enters the Bloodstream?. News-Medical, viewed 05 December 2019, https://www.news-medical.net/life-sciences/How-Much-CBD-and-THC-Enters-the-Bloodstream.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
Study finds declining trend in prevalence of cannabis use disorder among frequent users